Dr. Ed Baker
Roche Molecular diagnostics
Dr. Baker trained received his medical training at Loma Linda University. After completing his specialty training in Obstetrics and Gynecology, he practiced in the San Francisco bay area as a community physician for nearly 10 years.
In 2002 he became interested in drug development and took a position with Organon Pharmaceuticals, a company focused on Women’s health, where he ultimately became the head of the global Medical Affairs team for women’s health. He has been involved in the development and registration of dozens of products for women’s health and often lectures and writes on a variety of topics related to women’s health. Prior to his current position he was head of Medical Affairs at Actelion Pharmaceuticals, a company that focused its efforts on rare diseases.
He was attracted to his current position at Roche Molecular diagnostics because it presents a great opportunity to help shift a longstanding paradigm in cervical cancer screening. In addition to his work with Roche’s cervical cancer prevention portfolio he is also responsible for developmental projects in genetics and oncology and has a keen interest in the area of companion diagnostics.
Dr. Baker maintains his OB/GYN board certification and holds an appointment as Associate Professor of Medicine in the OB/GYN department at UC Davis.
1 blog from the author
Posted on 07.06.2018
Why should we prevent cervical cancer? Because we can
This blog is part of the Early Diagnosis campaign #BeFirstEarly diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice. Read the other blogs here: A […]